Patients who will diagnosed with breast cancer, and will be performed radical breast surgery without neoadjuvant chemotherapy. Patients who will diagnosed with clinically negative lymph node metastasis by using preoperative palpation, CT and MRI.
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who will be diagnosed with breast cancer and be performed radical breast surgery. Patients who will be performed surgery without neoadjuvant chemotherapy. Patients who will not be diagnosed with lymph node metastasis by palpation, CT and MRI.
Exclusion criteria
Exclusion criteria: Patients who will have possibility of pregnancy or patients who will be breast-feeding woman. Patients who will have allergy for contrast agent of ultrasound, egg and egg products. Patients who will have right-to-left shunt. Patients who will have severe heart disease or lung disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate whether the quantitative measurement of blood vessel density by contrast-enhanced ultrasound enables the diagnosis of lymph nodes micrometastases in breast cancer patients by setting appropriate threshold. | — |
Countries
Japan
Contacts
Tohoku University Graduate School of Medicine Department of Diagnostic Radiology